Member Info for mick-b

https://www.bbc.co.uk/sounds/play/live:bbc_radio_fourfm

WESTH1
I'll take a profit if the results are good but leave most of mine in. But my average is 0.47p so can afford to do so.
If you do sell around 2p, I would leave some in as we have TWO different sets of drilling results to come.
I've got no target in mine but the current price should double if the 1st set of drilling results.please the market

Now we have VLAD the "poisoner of underpants" as Navalny belittles Putin ..AGAIN!!

The best is STLL to come
All drilling is free for ORR under an agreement that exchanges a % interest in ORR prospects
So funding should be fine for awhile

A SHOCKER TRO...
2020 guidance was "US$850-895/oz AISC" and now they're talking about near $1500 for the last quarter and hoping for US$1,250 - 1,350/oz

Good job we are all out m8

RNS Award of New Licences Expands Cameroon Footprint

The Swedish Public Health Agency announced on Tuesday that it would not recommend the use of AstraZeneca's COVID-19 vaccine in people older than 65, television network TV4 reported.
The reason behind the decision is that the vaccine's effect on the elderly population is not documented well enough yet. However, other approved vaccines will primarily focus on providing immunity to the elderly, the country's health chief Soeren Andersson explained.
Sweden followed the steps of the German government, which originally pointed out issues related to using jab jointly developed by AstraZeneca and Oxford University. The European Union authorized the vaccine for emergency use last week.
Breaking the News / ND

The immunity from coronavirus induced by the Sputnik V vaccine, developed by the Gamaleya Research Institute of Epidemiology and Microbiology, could last for more than two years, the institute's Director Alexander Gintsburg said on Tuesday.
However, the matter is still "the subject of our further research," he told reporters at a press conference.
Commenting on the results of the Sputnik V trial published by The Lancet earlier in the day, Gintsburg noted that the vaccine's effectiveness was "approximately the same" across different age groups. "No serious complications were found among almost 30,000 subjects, except those minor side effects that were recorded in the first and second phases of the trial," he also specified.
Breaking the News / MS

He got me last night
After he told me he retired on health reasons....for me to express regret.....then to tell me the truth, it was the risk of working with COVID

lo!

Some say he's in hock with Russian banks too

PHE

1.40p buy

1.39p

Feed the birds....
Good lad!!
I buy big sacks of peanuts for mine.....mainly tits, jays and the common ones

Did U get snow overnight?

No RNS's have been released on this site...YET!!

BOOOOOOOOOOOO!!!

You B U G G E R!!
Got me there!!

Cant remember that but it is relevant to where I live
In the sticks without gas...so have oil C/H